Skip to main content
. 2015 May 27;17(5):401–409. doi: 10.1016/j.neo.2015.04.001

Table 2.

Genes Differentially Expressed in ECFCs Isolated from MDS Patients and Healthy Controls. The Upper Section Includes Genes Functional to Adhesion, Angiogenesis, Activation, Survival, and Apoptosis of Endothelial Cells; the Middle Section Includes Genes Belonging to the Wnt Pathway, and the Lower Section Includes miRNAs

Gene Fold Regulation P
ICAM-1 14.06 .012
Constitutive nitric oxide synthase 3 13.17 .015
SELL 7.26 .041
Tumor necrosis factor ligand superfamily, member 10 11.08 .019
VCAM-1 5.46 .008
vWF 6.86 .001
BCL2-like 1 − 8.51 .006
CASP2 and RIPK1 domain containing adaptor with death domain − 4.92 .032
MMP1 − 4.78 .002
FST 5.38 .043
BMP4 4.85 .001
Amino-terminal enhancer of split − 4.48 .001
Cyclin D1 − 5.59 .004
C-terminal binding protein 1 − 4.32 .003
Inhibitor of differentiation 2 − 4.96 .024
Wnt3A − 4.54 .010
Wnt5A − 4.51 .021
Wnt5B − 83.51 .031
miR-142-3p − 6.99 .003
miR-424-5p − 4.33 .001
miR-196b-5p − 9.89 .033